| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $738.7M | +17.2% |
| Cost of Revenue | $172.1M | +11.6% |
| Gross Profit | $566.6M | +19.1% |
| R&D Expense | $192.9M | +11.7% |
| SG&A Expense | $103.0M | -6.8% |
| Operating Income | -$76.5M | +19.0% |
| Interest Expense | $12.0M | -77.6% |
| Pre-tax Income | -$49.4M | +60.2% |
| Income Tax | $5.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $301.8M | +17.9% |
| Accounts Receivable | $148.4M | +18.6% |
| Current Assets | $1.05B | +3.9% |
| Total Assets | $1.37B | +12.3% |
| Current Liabilities | $592.4M | +22.3% |
| Total Liabilities | $1.41B | +7.8% |
| Stockholders' Equity | -$41.7M | +53.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $87.7M | +23.7% |
| Capital Expenditures | $1.4M | -35.8% |
| Investing Cash Flow | -$45.2M | +87.3% |
| Financing Cash Flow | $6.7M | -97.8% |
| Free Cash Flow | $86.3M | +25.6% |
| +63.4% |
| Net Income | -$55.0M | +56.8% |
| EPS (Basic) | -$0.99 | +58.1% |
| EPS (Diluted) | -$0.99 | +58.1% |